Literature DB >> 1746997

The impact of diuretic therapy on reported sexual function.

S W Chang1, R Fine, D Siegel, M Chesney, D Black, S B Hulley.   

Abstract

BACKGROUND: --Thiazide diuretics are the most commonly prescribed antihypertensive agent in the treatment of hypertension. No studies to date have isolated conclusively the effect of diuretic therapy on patient quality of life, and particularly on sexual dysfunction.
METHODS: --We carried out a randomized placebo-controlled trial of the effect of thiazide diuretics on quality of life in mildly hypertensive men between the ages of 35 and 70 years. After a 1-month washout period off diuretic therapy, the men were randomized to a 2-month trial of a thiazide treatment or placebo. At the end of the trial, 176 men completed a confidential self-administered questionnaire assessing aspects of social performance, general well-being, and emotional and physiologic states.
RESULTS: --Patients taking diuretics reported significantly greater sexual dysfunction than control subjects, including decreased libido, difficulty in gaining and maintaining an erection, and difficulty with ejaculation. Multivariate analysis suggested that the findings were not mediated by low serum potassium levels or by low blood pressure. Sexual dysfunction was noted more often in the confidential self-report questionnaire than in response to direct questions from clinicians. We found no differences between diuretic and placebo groups in measures of mood, general sense of well-being, ability to work, alertness, and social/recreational activities.
CONCLUSIONS: --Thiazide diuretic use is associated with male sexual dysfunction but does not appear to adversely affect other aspects of quality of life.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1746997

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  31 in total

1.  Reassessing quality-of-life instruments in the evaluation of new drugs.

Authors:  G H Guyatt; R J Jaeschke
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

Review 2.  Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs.

Authors:  Rainer Düsing
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Investigating correlates of health related quality of life in a low-income sample of patients with diabetes.

Authors:  F Camacho; R T Anderson; R A Bell; D C Goff; V Duren-Winfield; D D Doss; R Balkrishnan
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

4.  Insights and limitations from health-related quality-of-life research.

Authors:  G Guyatt
Journal:  J Gen Intern Med       Date:  1997-11       Impact factor: 5.128

Review 5.  Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials.

Authors:  I Côté; J P Grégoire; J Moisan
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

6.  Assessing sexual functioning in patients with chronic disorders by using a generic health-related quality of life questionnaire.

Authors:  P E Wändell; B Brorsson
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 7.  Drug-induced male sexual dysfunction. An update.

Authors:  G B Brock; T F Lue
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

8.  A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction.

Authors:  George F Lasker; Jason H Maley; Philip J Kadowitz
Journal:  Adv Pharmacol Sci       Date:  2010

Review 9.  A critical review of dimension-specific measures of health-related quality of life in cross-cultural research.

Authors:  M J Naughton; I Wiklund
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

10.  Evaluating the psychometric characteristics of the Psychological General Well-Being Index with a new response scale.

Authors:  D A Revicki; N K Leidy; L Howland
Journal:  Qual Life Res       Date:  1996-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.